ICRP, 1977.
Recommendations of the International Commission on Radiological
Protection. ICRP Publication 26. Ann. ICRP1 (3).
2.
ICRP, 1991b. 1990
Recommendations of the ICRP. ICRP Publication 60. Ann.
ICRP21 (1–3).
3.
ICRP, 1996b.
Conversion coefficients for use in radiological protection against
external radiation. ICRP Publication 74. Ann.
ICRP26 (3/4).
4.
ICRU, 1993b. Quantities and
units in radiation protection dosimetry. ICRU Report 51.
ICRU Publications: Bethesda,
MD.
5.
JacobiW., 1975. The concept of effective dose — A
proposal for the combination of organ doses. Radiat.
Environ. Biophys. 12,
101–109.
6.
ICRP, 1964. Recommendations
of the International Commission on Radiological Protection. ICRP
Publication 6. Pergamon Press,
Oxford, UK.
7.
ICRP, 1977.
Recommendations of the International Commission on Radiological
Protection. ICRP Publication 26. Ann. ICRP1 (3).
8.
ICRP, 1989b. RBE for
deterministic effects. ICRP Publication 58. Ann.
ICRP20 (4).
9.
ICRP, 1991b. 1990
Recommendations of the International Commission on Radiological
Protection. ICRP Publication 60. Ann. ICRP21 (1–3).
10.
ICRP, 2003a.
Biological effects after prenatal irradiation (embryo and
fetus). ICRP Publication 90. Ann. ICRP33 (1/2).
11.
ICRP, 2003c.
Relative biological effectiveness (RBE), quality factor (Q), and
radiation weighting factor (wR). ICRP Publication 92. Ann.
ICRP33 (4).
12.
NCRP, 1990. The Relative
Biological Effectiveness of Radiations of Different Quality. NCRP Report
No. 104. National Council on Radiation Protection and
Measurements, Bethesda,
MD.
13.
StrefferC.BoltH.FollesdalD., 2004. Low Dose Exposures in the Environment —
Dose-Effect Relations and Risk Evaluation.
Springer, Berlin-Heidelberg-New
York-Hong Kong-London-Milan-Paris-Tokyo.
14.
UNSCEAR, 2000. Sources and
Effects of Ionizing Radiation. Report of the United Nations Scientific
Committee on the Effects of Atomic Radiation. Volume II: Effects.
United Nations, New
York.
BigildeevE.A.MichalikV.WilhelmováL., 1992. Theoretical estimation of quality
factor for tritium. Health Phys.
63, 462–463.
17.
BinghamD.GardinI.HoyesK.P., 2000. The problem of Auger emitters for
radiological protection. In: Proc. Workshop on Environmental Dosimetry, Avignon,
September 1999. Radiat. Prot. Dosim.
92, 219–228.
18.
CERRIE, 2004. Report of the
Committee Examining Radiation Risks of Internal Emitters (CERRIE).
www.cerrie.org, ISBN
0-85951-545-1.
19.
CharlesM.W.MillA.J.DarleyP.J., 2003. Carcinogenic risk of hot-particle
exposures. J. Radiol. Prot. 23,
5–28.
20.
ChenJ.RoosH.KellererA.M., 2005. Radiation quality of photons in
small and large receptors — a microdosimetric analysis.
Radiat. Prot. Dosim. 118 (3),
238–242.
21.
DietzeG.HarderD., 2004. Proposal for a modified radiation
weighting factor for neutrons. Proceedings of the 11th International
Congress of IRPA. Available at www.irpa.net.
22.
DietzeG.SiebertB.R.L., 1994. Photon and neutron dose
contributions and mean quality factors in phantom of different size irradiated by
monoenergetic neutrons. Radiation Research140, 130–133.
23.
DietzeG.AlbertsW.G., 2004. Why it is advisable to keep wR = 1
and Q = 1 for photons and electrons. Radiat. Prot.
Dosim. 109 (4),
297–302.
24.
EdwardsA.A., 1997. The use of chromosomal aberrations
in human lymphocytes for biological dosimetry. Radiat.
Res. 148 (suppl.),
39–44.
25.
FrankenbergD.Frankenberg-SchwagerM.GargI., 2002. Mutation induction and neoplastic
transformation in human and human-hamster hybrid cells: dependence on photon
energy and modulation in the low dose range. J. Radiol.
Prot. 22,
A17–A20.
GodduS.M.HowellR.W.RaoD.V., 1996. Calculation of equivalent dose for
Auger electron emitting radionuclides distributed in human organs.
Acta Oncol. 35,
909–916.
28.
GoodheadD.T., 1994. Initial events in the cellular
effects of ionizing radiations: clustered damage in DNA.
Int. J. Rad. Biol. 65,
7–17.
29.
GragtmansN.J.MyersD.K.JohnsonJ.R., 1984. Occurrence of mammary tumours in
rats after exposure to tritium beta rays and 200 kVp x rays.
Radiat. Res. 99,
636–650.
30.
Guerrero-CarbajalC.EdwardsA.A.LloydD.C., 2003. Induction of chromosome aberration
in human lymphocytes and its dependence on x-ray energy.
Radiat. Prot. Dosim. 106 (2),
131–135.
31.
HarderD.Petoussi-HenssN.RegullaD., 2004. Spectra of scattered photons in
large absorbers and their importance for the values of the radiation weighting
factor wR. Radiat. Prot. Dosim.
109 (4),
291–295.
32.
HarrisonJ.D.MuirheadC.R., 2003. Quantitative comparisons of cancer
induction in humans by internally deposited radionuclides and external
radiation. Int. J. Radiat. Biol.
79, 1–13.
33.
HoferK.G.HarrisC.R.SmithJ.M., 1975. Radiotoxicity of intracellular
67Ga, 125I and 3H: nuclear versus cytoplasmic radiation effects in murine L1210
cells. Int. J. Radiat. Biol. 28,
225–241.
34.
HowellR.W.NarraV.R.SastryK.S.R., 1993. On the equivalent dose for Auger
electron emitters. Radiat. Res.
134, 71–78.
35.
ICRP/ICRU, 1963.
Report of the RBE Committee of the International Commissions on
Radiological Protection and on Radiation Units and Measurements.
Health Phys. 9,
357.
36.
ICRP, 1966. Recommendations
of the International Commission on Radiological Protection. ICRP
Publication 9. Pergamon Press,
Oxford, UK.
37.
ICRP, 1977.
Recommendations of the International Commission on Radiological
Protection. ICRP Publication 26. Ann. ICRP1 (3).
38.
ICRP, 1979. Limits
for the intake of radionuclides by workers. ICRP Publication 30.
Part 1. Ann. ICRP2 (3/4).
39.
ICRP, 1980.
Biological effects of inhaled radionuclides. ICRP
Publication 31. Ann. ICRP4 (1/2).
40.
ICRP, 1991b. 1990
Recommendations of the ICRP. ICRP Publication 60. Ann.
ICRP21 (1–3).
41.
ICRP, 1993c.
Age-dependent doses to members of the public from intake of
radionuclides: Part 2. Ingestion dose coefficients. ICRP
Publication 67. Ann. ICRP23 (3/4).
42.
ICRP, 1994a. Human
respiratory tract model for radiological protection. ICRP
Publication 66. Ann ICRP24 (1–3).
43.
ICRP, 1994b. Dose
coefficients for intake of radionuclides by workers. ICRP
Publication 68. Ann. ICRP24 (4).
44.
ICRP, 1995a.
Age-dependent doses to members of the public from intake of
radionuclides: Part 3: Ingestion dose coefficients. ICRP
Publication 69. Ann. ICRP25 (1).
45.
ICRP, 1996b.
Conversion coefficients for use in radiological protection against
external radiation. ICRP Publication 74. Ann.
ICRP26 (3/4).
46.
ICRP, 1996c.
Age-dependent doses to members of the public from intake of
radionuclides: Part 5 Compilation of ingestion and inhalation dose
coefficients. ICRP Publication 72. Ann. ICRP26 (1).
47.
ICRP, 2001. Doses to
the embryo and embryo/fetus from intakes of radionuclides by the
mother. ICRP Publication 88. Ann. ICRP31 (1–3).
48.
ICRP, 2002. Basic
anatomical and physiological data for use in radiological
protection. ICRP Publication 89. Ann. ICRP32 (3–4).
49.
ICRP, 2003a.
Biological effects after prenatal irradiation (embryo and
fetus). ICRP Publication 90. Ann. ICRP33 (1/2).
50.
ICRP, 2003c.
Relative biological effectiveness (RBE), quality factor (Q), and
radiation weighting factor (wR). ICRP Publication 92. Ann.
ICRP33 (4).
51.
ICRP, 2006c. Human
alimentary tract model for radiological protection. ICRP
Publication 100. Ann. ICRP36 (1/2).
52.
ICRU, 1970. Linear Energy
Transfer. ICRU Report 16. ICRU
Publications: Bethesda
(MD).
53.
ICRU, 1986. The Quality
Factor in Radiation Protection. ICRU Report 40. ICRU
Publications: Bethesda
(MD).
54.
ICRU, 1998. Fundamental
Quantities and Units for Ionizing Radiation. ICRU Report 60.
ICRU Publications: Bethesda,
MD.
55.
JohnsonJ.R.MyersD.K.JacksonJ.S., 1995. Relative biological effectiveness
of tritium for induction of myeloid leukaemia. Radiat.
Res. 144,
82–89.
56.
KassisA.I.FayedF.KinseyB.M., 1989. Radiotoxicity of an I-125 labeled
DNA intercalator in mammalian cells. Radiat. Res.
118, 283–294.
57.
KellererA.M.LeutholdG.MaresV., 2004. Options for the modified radiation
weighting factor of neutrons. Radiat. Prot.
Dosim. 109 (3),
181–188.
58.
LafumaJ.NenotJ.C.MorinM., 1974. Respiratory carcinogenesis in rats
after inhalation of radioactive aerosols of actinides and lanthanides in various
chemical forms. In: Experimental Lung Cancer.
KarbeE.ParksJ.F. (eds) Vol. 1, p.
443–453, Springer
Verlag, New York.
59.
MoiseenkoV.V.WalkerA.J.PrestwichW.V., 1997. Energy deposition pattern from
tritium and different energy photons-a comparative study.
Health Phys. 73,
388–39.
60.
MorstinK.KopecM.OlkoP., 1993. Microdosimetry of
tritium. Health Phys. 65,
648–656.
61.
NCRP, 1990. The Relative
Biological Effectiveness of Radiations of Different Quality. NCRP Report
No. 104. National Council on Radiation Protection and
Measurements, Bethesda,
MD.
62.
NelsonC.B.PhippsA.W.SilkT.J., 1997. The ICRP Publication 60
formulation of remainderdose and its contribution to effective dose in internal
dosimetry. Radiat. Prot. Dosim.
71, 33–40.
63.
NolteR.M.ÜhlbradtK.H.MeuldersJ.P., 2005. RBE of quasi-monoenergetic 60 MeV
neutronradiation for induction of dicentric chromosome aberrations in human
lymphocytes. Radiat. Environ. Biophys.
44, 201–209.
64.
PelliccioniM., 1998. Radiation weighting factors and
high energy radiation. Radiat. Prot. Dosim.
80 (4),
371–378.
65.
PelliccioniM., 2004. The impact of ICRP Publication 92
on the conversion coefficients in use for cosmic ray dosimetry.
Radiat. Prot. Dosim. 109 (4),
303–309.
66.
RaoD.V.NarraV.R.HowellR.W., 1990. Biological consequences of nuclear
versus cytoplasmic decays of 125I: cysteamine as a radioprotector against Auger
cascades in vivo. Radiat. Res.
124, 188–193.
67.
SasakiM.S., 1991. Primary damage and fixation of
chromosomal DNA as probed by monochromatic softx rays and low-energy
neutrons. In: FieldenE.M.O'NeilP. (Eds.). The Early Effects of Radiation on DNA. NATO
ASI Series, Vol. H54, 369–384.
Springer Verlag, Berlin,
Germany.
68.
SatoT.TsudaS.SakamotoY., 2003. Analysis of dose-LET distribution
in the human body irradiated by high energy hadrons.
Radiat. Prot. Dosim. 106,
145–153.
69.
SatoT.TsudaS.SakamotoY., 2004. Profile of energy deposition in
human body irradiated by heavy ions. J. Nucl. Sci.
Technol. Suppl. 4,
287–290.
70.
SchmidE.RegullaD.KramerH.M., 2002. The effect of 29 kV x rays on the
dose response of chromosome aberrations in human lymphocytes.
Radiat. Res. 158,
771–777.
71.
SchmidE.SchlegelD.GuldbakkeS., 2003. RBE of nearly monoenergetic
neutrons at energies of 36 keV — 14.6 MeV for induction of dicentrics in human
lymphocytes. Radiat. Environm. Biophys.
42, 87–94.
72.
SSK, 2005.
Bundesministerium für Umwelt, Naturschutz und Reaktorsicherheit.
Vergleichende Bewertung der biologischen Wirksamkeit verschiedener ionisierender
Strahlungen. Veröffentlichungen der
Strahlenschutzkommission, Bd. 53. Verlag
Elsevier/Urban und Fischer.
73.
StraumeT.CarstenA.L., 1993. Tritium radiobiology and relative
biological effectiveness. Health Phys.
65, 657–672.
74.
StrefferC.van BeuningenD.EliasS., 1978. Comparative effects of tritiated
water and thymidine on the preimplanted mouse embryo in vitro.
Curr. Topics Radiat. Res. Q. 12,
182–193.
75.
StrefferC., 2005. Can tissue weighting factors be
established for the embryo and fetus?. Radiat. Prot.
Dosim. 112,
519–523.
76.
UenoA.M.Furuno-FukushiI.MatsudairaH., 1989. Cell killing and mutation to
6-thioguanine resistance after exposure to tritiated amino acids and tritiated
thymidine in cultured mammalian cells. In: Tritium
Radiobiology and Health Physics (Ed., OkadaS.). Proc. 3rd Japanese—US Workshop. Nagoya
University, Japan. IPPJ-REV-3,
200–210.
77.
UNSCEAR, 1993.
Sources and Effects of Ionizing Radiation. Report
of the United Nations ScientificCommittee on the Effects of Atomic Radiation.
Annex F. Influence of dose and dose rate on stochastic effects of
radiation. United Nations,
New York, NY.
78.
UNSCEAR, 2000. Sources and
Effects of Ionizing Radiation. Report of the United Nations Scientific
Committee on the Effects of Atomic Radiation. Volume II: Effects.
United Nations, New
York.
79.
WartersR.L.HoferK.G.HarrisC.R., 1978. Radionuclide toxicity in cultured
mammalian cells: elucidation of the primary site of radiation
damage. Curr. Topics Radiat. Res. Q.
12, 389–407.
80.
WHO, 2001. IARC Monographs
on the evaluation of carcinogenic risks to humans. Vol. 78. Ionizing
Radiation, Part 2: some internally deposited radionuclides. World Health
Organisation, International Agency for Research on Cancer. IARC
Press, Lyon.
81.
YoshizawaN.SatoO.TakagiS., 1998. External radiation conversion
coefficients using radiation weighting factor and quality factor for neutron and
proton from 20 MeV to 10 GeV. Nucl. Sci. Techn.
35 (12),
928–942.
82.
BerkovskiV.BonchukY.RatiaG., 2003. Dose per unit content functions: a
robust tool for the interpretation of bioassay data. Proc Workshop
on Internal Dosimetry of Radionuclides. Radiat. Prot. Dosim.
105 (1/4),
399–402.
83.
EU, 1996. Council of
the European Union: Council Directive on laying down the Basic Safety Standardsfor
the protection of the health of workers and the general public against the dangers
arising from ionising radiation. Official. J. Eur.
Community39, No. L, 159.
84.
IAEA, 1996. International
Basic Safety Standards for Protection against Ionizing Radiation and for the
Safety of Radiation Sources. Safety Series 115. STI/PUB/996.
International Atomic Energy Agency,
Vienna, Austria.
85.
ICRP, 1991b. 1990
Recommendations of the ICRP. ICRP Publication 60. Ann.
ICRP21 (1–3).
86.
ICRP, 1994b. Dose
coefficients for intake of radionuclides by workers. ICRP
Publication 68. Ann. ICRP24 (4).
87.
ICRP, 1996c.
Age-dependent doses to members of the public from intake of
radionuclides: Part 5. Compilation of ingestion and inhalation dose
coefficients. ICRP Publication 72. Ann. ICRP26 (1).
88.
ICRP, 2003c.
Relative biological effectiveness (RBE), quality factor (Q), and
radiation weighting factor (wR). ICRP Publication 92. Ann.
ICRP33 (4).
89.
ICRU, 1985. Determination
of dose equivalents resulting from external radiation sources. ICRU
Report 39. ICRU Publications:
Bethesda, MD.
90.
ICRU, 1988. Measurement of
dose equivalents from external radiation sources, Part 2. ICRU Report 43.
ICRU Publications: Bethesda,
MD.
91.
ICRU, 1993b. Quantities and
units in radiation protection dosimetry. ICRU Report 51.
ICRU Publications: Bethesda,
MD.
92.
ICRU, 1998. Fundamental
quantities and units for ionizing radiation. ICRU Report 60.
ICRU Publications: Bethesda,
MD.
93.
ICRU, 2001b.
Determination of operational dose equivalent quantities for
neutrons. ICRU Report 66. Journal of ICRU1 (3).
94.
PelliccioniM., 1998. Radiation weighting factors and
high energy radiation. Radiat. Prot. Dosim.
80
(4),371–378.
95.
CristyM.EckermanK.F., 1987. Specific absorbed fractions of energy at
various ages from internal photon sources. Oak Ridge,
TN: Oak Ridge National Laboratory
Report ORNL/TM-8381: Vol. 1–7.
96.
EndoA.YamaguchiY.EckermanK.F., 2003. Development and assessment of a
new radioactive decay database used for dosimetry calculations.
Radiat. Prot. Dosim. 105 (1/4),
565–569.
97.
EndoA.YamaguchiY.EckermanK.F., 2005. Nuclear Decay Data for Dosimetry Calculation:
Revised Data of ICRP Publication 38. JAERI 1347.
98.
ICRP, 1977.
Recommendations of the International Commission on Radiological
Protection. ICRP Publication 26. Ann. ICRP1 (3).
99.
ICRP, 1983b.
Radionuclide Transformation: energy and intensity of
emissions. ICRP Publication 38. Ann. ICRP11–13.
100.
ICRP, 1989b. RBE for
deterministic effects. ICRP Publication 58. Ann.
ICRP20 (4).
101.
ICRP, 1991b. 1990
Recommendations of the ICRP. ICRP Publication 60. Ann.
ICRP21 (1–3).
102.
ICRP, 1993b.
Protection against radon-222 at home and at work.
ICRP Publication 65. Ann. ICRP23 (2).
103.
ICRP, 1996b.
Conversion coefficients for use in radiological protection against
external radiation. ICRP Publication 74. Ann.
ICRP26 (3/4).
104.
ICRP, 1996c.
Age-dependent doses to members of the public from intake of
radionuclides: Part 5. Compilation of ingestion and inhalation dose
coefficients. ICRP Publication 72. Ann. ICRP26 (1).
105.
ICRP, 2002. Basic
anatomical and physiological data for use in radiological
protection. ICRP Publication 89. Ann. ICRP32 (3/4).
106.
ICRU, 1997. Conversion
coefficients for use in radiological protection against external
radiation. International Commission on Radiation Units
and Measurements, Bethesda,
MD.
107.
ICRU, 2001b.
Determination of operational dose equivalent quantities for
neutrons. ICRU Report 66. Journal of ICRU1 (3).
108.
IEC, 2005. International
Electrotechnical Vocabulary (IEV). Online database. IEV 393-04-13,
393-04-14, 393-04-15. International Electrotechnical
Commission, Geneva,
Switzerland.
109.
ISO, 1992. Quantities and
Units. ISO 31-9-34, 31-9-35, 31-9-36 (E). International
Organization for Standardization, Geneva,
Switzerland.
110.
KaulA.AurandK.BonkaH., 1987. Possibilities and limits for
applying the concept of collective dose. Health
Phys. 53,
9–10.
111.
KramerR.ZanklM.WilliamsG.DrexlerG., 1982. The calculation of dose from external
photonexposures using reference human phantoms and Monte Carlo methods, Part I:
The male (Adam) and female (Eva) adult mathematical phantoms.
Neuherberg, Germany: GSF-Report S-885,
GSF-National Research Center for Environment and
Health.
112.
NCRP, 1990. The Relative
Biological Effectiveness of Radiations of Different Quality. NCRP Report
No. 104. National Council on Radiation Protection and
Measurements, Bethesda
MD.
113.
NCRP, 2006. Development of
a Biokinetic Model for Radionuclide-Contaminated Wounds and Procedures for Their
Assessment, Dosimetry and Treatment. NCRP Report No. 156.
National Council on Radiation Protection and
Measurements, Bethesda,
MD.
114.
SchlattlH.ZanklM.Petoussi-HenssN., 2007. Organ dose conversion coefficients
for voxel models of the reference male and female from idealized photon
exposures. Phys. Med. Biol. 52,
2123–2145.
115.
UNSCEAR, 1988. Sources,
Effects and Risks of Ionizing Radiation. Report of the United Nations
Scientific Committee on the Effects of Atomic Radiation. Annex C. Exposures from
medical uses of radiation.
116.
UNSCEAR, 2000. Sources and
Effects of Ionizing Radiation. Report of the United Nations Scientific
Committee on the Effects of Atomic Radiation. Volume II: Effects.
United Nations, New
York.
117.
ZanklM.FillU.Petoussi-HenssN.RegullaD., 2002. Organ dose conversion coefficients
for external photon irradiation of male and female voxel phantoms.
Phys. Med. Biol. 47 (14),
2367–2385.
118.
ZanklM.BeckerJ.FillU., 2005. GSF male and female adult voxel models
representing ICRP Reference Man — the present status. Proceedings of The
Monte Carlo Method: Versatility Unbounded in a Dynamic Computing World. Chattanooga,
TN, American Nuclear Society, La
Grange Park, USA.
119.
ZanklM.EckermanK.F.BolchW.E., 2007. Voxel-based models representing
the male and female ICRP reference adult — the skeleton.
Radiat. Prot. Dosim. 127.
120.
CERRIE, 2004. Report of the
Committee Examining Radiation Risks of Internal Emitters (CERRIE).
www.cerrie.org, ISBN
0-85951-545-1.
121.
HarrisonJ.D.LeggettR.W.NoßkeD., 2001. Reliability of the ICRP's dose
coefficients for members of the public, II. Uncertainties in the absorption of
ingested radionuclides and the effect on dose estimates.
Radiat. Prot. Dosim. 95,
295–308.
122.
ICRP, 1991b. 1990
Recommendations of the ICRP. ICRP Publication 60. Ann.
ICRP21 (1–3).
123.
ICRP, 2002. Basic
anatomical and physiological data for use in radiological
protection. ICRP Publication 89. Ann. ICRP32 (3/4).
124.
ICRP, 2006c. Human
alimentary tract model for radiological protection. ICRP
Publication 100. Ann. ICRP36 (1/2).
125.
LeggettR.W.BouvilleA.EckermanK.F., 1998. Reliability of the ICRP's systemic
biokinetic models. Radiat. Protect. Dosim.
79, 335–342.
126.
LikhtarevI.MinenkoV.KhrouchV., 2003. Uncertainties in thyroid dose
reconstruction after Chernobyl. Radiat. Prot.
Dosim. 105,
601–608.
127.
UNSCEAR, 2000. Sources and
Effects of Ionizing Radiation. Report of the United Nations Scientific
Committee on the Effects of Atomic Radiation. Volume II: Effects.
United Nations, New
York.
128.
AFRRI Contract Report 94–1, 1994.
Analysis of chronic radiation sickness cases in the population of the
Southern Urals. AFRRI,
Bethesda, Maryland, USA.
129.
AFRRI Contract Report 98–1, 1998.
Chronic radiation sickness among Techa Riverside Residents.
AFRRI, Bethesda, Maryland,
USA.
130.
AkleyevA.V.KisselyovM.F. (Eds.), 2002. Medical-biological and ecological
impacts of radioactive contamination of the Techa river.
Fregat,
Chelyabinsk. ISBN5-88931-026-7.
131.
AkleyevA.VeremeyevaG.A.SilkinaL.A., 1999. Long-term hemopoiesis and immunity
status after chronic radiation exposure of red bone marrow in
humans. Central European Journal of Occ. and Env.
Medicine5, 113–129.
132.
AlemanB.M.van den Belt-DuseboutA.W.KlokmanW.J., 2003. Long-term cause-specific mortality
of patients treated for Hodgkin's disease. J. Clin.
Oncol. 21,
3431–3439.
BerkovskiV.BonchukY.RatiaG., 2003. Dose per unit content functions: a
robust tool for the interpretation of bioassay data. Proc. Workshop on Internal
Dosimetry of Radionuclides. Radiat. Prot. Dosim.
105, 399–402.
135.
BigildeevE.A.MichalikV.WilhelmováL., 1992. Theoretical estimation of quality
factor for tritium. Health Phys.
63, 462–463.
136.
BinghamD.GardinI.HoyesK.P., 2000. The problem of Auger emitters for
radiological protection. In: Proc. Workshop on Environmental
Dosimetry, Avignon, September 1999. Radiat. Prot. Dosim.
92, 219–228.
137.
BolchW.E.FarfanE.B.HustonT.E., 2003. Influences of parameter
uncertainties within the ICRP-66 respiratory tract model: particle
clearance. Health Physics,
84(4)
421–435.
138.
BrewerC.HollowayS.ZawalnyskiP., 1998. A chromosomal deletion map of
human malformations. Am. J. Hum. Genet.
63, 1153–1159.
139.
CardisE.VrijheidM.BlettnerM., 2005. Risk of cancer after low doses of
ionising radiation: retrospective cohort study in 15 countries.
Br. Med. J. 331,
77–80.
140.
CarterC.O., 1961. The inheritance of pyloric
stenosis. Brit. Med. Bull. 17,
251–254.
141.
CarterC.O., 1977. Monogenic
disorders. J. Med. Genet. 14,
316–320.
142.
CattanachB.M.BurtenshawM.D.RasberryC., 1993. Large deletions and other gross
forms of chromosome imbalance compatible with viability and fertility in the
mouse. Nature Genet. 3,
56–61.
143.
CattanachB.M.EvansE.P.RasberryC., 1996. Incidence and distribution of
radiation-induced large deletions in the mouse. In: HagenU.HarderD.JungH. (Eds.), Congress Proceedings, Tenth Int. Cong. Radiat. Res.,
Vol. 2, Würzburg, Germany, pp.
531–534.
144.
CERRIE, 2004. Report of the
Committee Examining Radiation Risks of Internal Emitters (CERRIE).
www.cerrie.org, ISBN
0-85951-545-1.
145.
ChakrabortyR.YasudaN.DennistonC., 1998. Ionizing radiation and genetic
risks. VII. The concept of mutation component and its use in risk estimation for
mendelian diseases. Mutat. Res.
400, 41–52.
146.
CharlesM.W.MillA.J.DarleyP.J., 2003. Carcinogenic risk of hot-particle
exposures. J. Radiol. Prot. 23,
5–28.
147.
ChenJ.RoosH.KellererA.M., 2005. Radiation quality of photons in
small and large receptors — a microdosimetric analysis.
Radiat. Prot. Dosim. 118,
238–242.
148.
CherubiniR.GoodheadD.T.MenzelH.G. (Eds.), 2002. Proceedings of the 13th
Symposium on Microdosimetry. Radiat. Prot. Dosim.
99, Nos. 1–4.
149.
CoxR.EdwardsA.A., 2002. Comments on the paper:
Microsatellite instability in acute myelocylic leukaemia developed from A-bomb
survivors and related cytogenetic data. Int. J. Radiat.
Biol. 78,
443–445.
150.
CristyM.EckermanK.F., 1987. Specific absorbed fractions of energy at
various ages from internal photon sources. Report ORNL/TM-8381:
Vol. 1–7. Oak Ridge National
Laboratory, Oak Ridge,
TN.
151.
CrowJ.F.DennistonC., 1981. The mutation component of genetic
damage. Science212, 888–893.
152.
CrowJ.F.DennistonC., 1985. Mutation in human
populations. In: HarrisH.HirschhornH. (Eds.), Adv. Hum. Genet. Vol. 12,
Plenum Press,
NewYork, pp.
59–123.
153.
CzeizelA.SankaranarayananK., 1984. The load of genetic and partially
genetic disorders in man. I. Congenital anomalies: estimates of detriment in terms
of years lost and years of impaired life. Mutat.
Res. 128,
73–103.
154.
CzeizelA.SankaranarayananK.LosonciA., 1988. The load of genetic and partially
genetic disorders in man. II. Some selected common multifactorial diseases.
Estimates of population prevalence and of detriment in terms of years lost and
impaired life. Mutat. Res. 196,
259–292.
155.
DarbyS.HillD.AuvinenA., 2005. Radon in homes and risk of lung
cancer: collaborative analysis of individual data from 13 European case-control
studies. Br. Med. J. 330,
223–226.
156.
DarbyS.HillD.DeoH., 2006. Residential radon and lung cancer
— detailed results of acollaborative analysis of individual data on 7148 persons
with lung cancer and 14,208 persons without lung cancer from 13 epidemiologic
studies in Europe. Scand. J. Work Environ. Health32 (Suppl. 1),
1–84.
157.
DennistonC.ChakrabortyR.SankaranarayananK., 1998. Ionizing radiation and genetic
risks. VIII. The concept of mutation component and its use in risk estimation for
multifactorial diseases. Mutat. Res.
405, 7–79.
158.
DietzeG.AlbertsW.G., 2004. Why it is advisable to keep wR = 1
and Q = 1 for photons and electrons. Radiat. Prot.
Dosim. 109,
297–302.
159.
DietzeG.HarderD., 2004. Proposal for a Modified Radiation
Weighting Factor for Neutrons. Proceedings of the 11th International
Congress of IRPA. Available from www.irpa.net.
160.
DietzeG.SiebertB.R.L., 1994. Photon and neutron dose
contributions and mean quality factors in phantom of different size irradiated by
monoenergetic neutrons. Radiat. Res.
140, 130–133.
161.
DörrW.HendryJ.H., 2001. Consequential late effects in
normal tissue. Radiother. Oncol.
61, 223–231.
162.
Early Breast Cancer Trialists' Collaborative
Group, 2000. Favourable and unfavourable
effects on long-term survival of radiotherapy for early breast cancer: an overview
of the randomised trials. Lancet355, 1757–1770.
163.
EckermanK.F.WestfallR.J.Ryman, 1994. Availability of nuclear decay data
in electronic form, including beta spectra not previously
published. Health Phys. 67,
338–345.
164.
EdwardsA.A., 1997. The use of chromosomal aberrations
in human lymphocytes for biological dosimetry. Radiat.
Res. 148 (suppl.),
39–44.
165.
EdwardsA.A.LloydD.C., 1996. Risk from deterministic effects of
ionising radiation. Doc. NRPBVol. 7No.3.
166.
EhlingU.H., 1965. The frequency of X-ray-induced
dominant mutations affecting the skeleton in mice.
Genetics51, 723–732.
167.
EhlingU.H., 1966. Dominant mutations affecting the
skeleton in offspring of X-irradiated male mice.
Genetics54, 1381–1389.
168.
EllenderM.HarrisonJ.D.EdwardsA.A., 2005. Direct single gene mutational
events account for radiation-induced intestinal adenoma yields in Apc (min/+)
mice. Radiat. Res. 163,
552–556.
169.
EndoA.YamaguchiY.EckermanK.F., 2003. Development and assessment of a
new radioactive decay database used for dosimetry calculations.
Radiat. Prot. Dosim. 105 (1/4),
565–569.
170.
EndoA.YamaguchiY.EckermanK.F., 2005. Nuclear Decay Data for Dosimetry
Calculation: Revised Data of ICRP Publication 38.
JAERI1347.
171.
EPA, 1999. Estimating
Radiogenic Cancer Risks. Addendum: Uncertainty Analysis.
U.S. Environmental Protection Agency,
Washington, D.C..
172.
EU, 1996. Council of
the European Union: Council Directive on laying down the Basic Safety Standards
for the protection of the health of workers and the general public against the
dangers arising from ionising radiation. Official. J. Eur.
Community39, No. L, 159.
173.
FalconerD.S., 1960. Introduction to Quantitative
Genetics, Oliver and Boyd,
Edinburgh.
174.
FalconerD.S., 1965. The inheritance of liability to
certain diseases, estimated from the incidence among relatives.
Ann. Hum. Genet. (Lond)29, 51–76.
175.
FarfanE.B.BolchW.E.HustonT.E., 2005. Uncertainties in electron-absorbed
fractions and lung doses from inhaled beta-emitters.
Health Physics88 (1),
37–47.
176.
FavorJ., 1989. Risk estimation based on germ cell
mutations in animals. Genome31, 844–852.
177.
FillU.A.ZanklM.Petoussi-HenssN., 2004. Adult female voxel models of
different stature and photon conversion coefficients.
Health Phys. 86 (3),
253–272.
178.
FrankenbergD.Frankenberg-SchwagerM.GargI., 2002. Mutation induction and neoplastic
transformation in human and human-hamster hybrid cells: dependence on photon
energy and modulation in the low dose range. J. Radiol.
Prot. 22,
A17–A20.
GodduS.M.HowellR.W.RaoD.V., 1996. Calculation of equivalent dose for
Auger electron emitting radionuclides distributed in human organs.
Acta Oncol. 35,
909–916.
182.
Goodhead, D.T., 1994.
Initial events in the cellular effects of ionizing radiations:
clustered damage in DNA. Int. J. Rad. Biol.
65, 7–17.
183.
GoodheadD.G.O'NeillP.MenzelH.G. (Eds.), 1996. Microdosimetry: An
interdisciplinary approach. Proceedings of the 12th Symposium on
Microdosimetry. Royal Society of Chemistry,
Cambridge.
GragtmansN.J.MyersD.K.JohnsonJ.R., 1984. Occurrence of mammary tumours in
rats after exposure to tritium beta rays and 200 kVp x-rays.
Radiat. Res. 99,
636–650.
186.
GreenE.L., 1968. Genetic effects of radiation on
mammalian populations. Ann. Rev. Genet.
2, 87–120.
187.
Guerrero-CarbajalC.EdwardsA.A.LloydD.C., 2003. Induction of chromosome aberration
in human lymphocytes and its dependence on x-ray energy.
Radiat. Prot. Dosim. 106,
131–135.
188.
GuskovaA.K.GusevI.A.OkladnikovaN.D., 2002. Russian concepts of chronic
radiation disease in man. Br. J. Radiol. Supp.
26, 19–23.
189.
HallP.GranathF.LundellM., 1999. Lenticular opacities in
individuals exposed to ionising radiation in infancy.
Radiat. Res. 152,
190–195.
190.
HancockS.L.TuckerM.A.HoppeR.T., 1993. Factors affecting late mortality
from heart disease after treatment of Hodgkin's disease.
J. Am. Med. Assoc. 270,
1949–1955.
191.
HarderD.Petoussi-HenssN.RegullaD., 2004. Spectra of scattered photons in
large absorbersand their importance for the values of the radiation weighting
factor wR. Radiat. Prot. Dosim.
109, 291–295.
192.
HarrisonJ.D.LeggettR.W.NosskeD., 2001. Reliability of the ICRP's dose
coefficients for members of the public, II. Uncertainties in the absorption of
ingested radionuclides and the effect on dose estimates.
Radiat. Prot. Dosim. 95,
295–308.
193.
HarrisonJ.D.MuirheadC.R., 2003. Quantitative comparisons of cancer
induction in humans by internally deposited radionuclides and external
radiation. Int. J. Radiat. Biol.
79, 1–13.
194.
HayashiT.KusunokiY.HakodaM., 2003. Radiation dose-dependent increases
in inflammatory response markers in A-bomb survivors. Int.
J. Radiat. Biol. 79,
129–136.
195.
HendryJ.H., 1994. Biological response modifiers and
normal tissue injury after irradiation. Seminars in
Radiation Oncology4, 123–132.
196.
HendryJ.H.ThamesH.D., 1987. Fractionation in Radiotherapy.
Taylor and Francis,
London.
197.
HoferK.G.HarrisC.R.SmithJ.M., 1975. Radiotoxicity of intracellular
67Ga, 125I and 3H: nuclear versus cytoplasmic radiation effects in murine L1210
cells. Int. J. Radiat. Biol. 28,
225–241.
198.
HowellR.W.NarraV.R.SastryK.S.R., 1993. On the equivalent dose for Auger
electron emitters. Radiat. Res.
134, 71–78.
199.
IAEA, 1982. Basic Safety
Standards for Radiation Protection, 1982 Edition. Safety Series No. 9.
STI/PUB/607. International Atomic Energy Agency,
Vienna, Austria.
200.
IAEA, 1996. International
Basic Safety Standards for Protection against Ionizing Radiation and for the
Safety of Radiation Sources. Safety Series 115. STI/PUB/996.
International Atomic Energy Agency,
Vienna, Austria.
201.
IAEA, 1999. Occupational
radiation protection. Safety Guide RS-G-1.1.
International Atomic Energy Agency,
Vienna, Austria.
202.
IAEA, 2000a. Legal and
Governmental Infrastructure for Nuclear, Radiation, Radioactive Waste and
Transport Safety. Safety Requirements; Safety Standards
GS-R-1.STI/PUB/1093. International Atomic Energy
Agency, Vienna,
Austria.
203.
IAEA, 2000b. Regulatory
Control of Radioactive Discharges to the Environment. Safety Guide
WS-G-2.3. STI/PUB/1088. International Atomic Energy
Agency, Vienna,
Austria.
204.
IAEA, 2001. National
Regulatory Authorities with Competence in the Safety of Radiation Sources and the
Security of Radioactive Materials. Proceedings of an International
Conference in Buenos Aires, Argentina, 11–15 December 2000. IAEA-CSP-9/P.
International Atomic Energy Agency,
Vienna, Austria.
205.
IAEA, 2002. Preparedness
and Response for a Nuclear or Radiological Emergency, Safety
Requirements, Safety Standards Series No. GS-R-2. STI/PUB/1133.
International Atomic Energy Agency,
Vienna, Austria.
206.
IAEA, 2004. Code of Conduct
on the Safety and Security of Radioactive Sources.
International Atomic Energy Agency,
Vienna, Austria.
207.
IARC, 2000. IARC
monographs on the evaluation of carcinogenic risks to humans: Volume
75. Ionizing radiation, Part I, X and gamma radiation and
neutrons. IARC Press,
Lyon.
208.
IARC, 2001. IARC
monographs on the evaluation of carcinogenic risks to humans: Volume
78. Ionizing radiation, Part 2: some internally deposited
radionuclides. IARC Press,
Lyon.
209.
ICNIRP, 2004. ICNIRP
Publications 1992–2004. A reference CD-ROM based on guidelines on limiting
exposure to non-ionizing radiation and statements on special
applications. MatthesR.BernhardtJ.H.McKinlayA.F. (eds) International Commission on Non-Ionizing Radiation
Protection, Munich, Germany. ISBN 3-934994-05-9.
210.
ICRP, 1951.
International Recommendations on Radiological Protection. Revised
by the International Commission on Radiological Protection and the 6th
International Congress of Radiology, London, 1950. Br. J.
Radiol. 24,
46–53.
211.
ICRP, 1955.
Recommendations of the International Commission on Radiological
Protection. Br. J. Radiol., Suppl.
6.
212.
ICRP, 1957. Reports
on Amendments during 1956 to the Recommendations of the International Commission
on Radiological Protection (ICRP). Acta. Radiol.
48, 493–495.
213.
ICRP, 1959. Recommendations
of the International Commission on Radiological Protection. ICRP
Publication 1. Pergamon Press,
Oxford, UK.
214.
ICRP/ICRU, 1963.
Report of the RBE Committee of the International Commissions on
Radiological Protection and on Radiation Units and Measurements.
Health Phys. 9,
357.
215.
ICRP, 1964. Recommendations
of the International Commission on Radiological Protection. ICRP
Publication 6. Pergamon Press,
Oxford, UK.
216.
ICRP, 1966. Recommendations
of the International Commission on Radiological Protection. ICRP
Publication 9, Pergamon Press,
Oxford, UK.
217.
ICRP, 1973. Implications of
Commission Recommendations that Doses Be Kept As Low As Readily
Achievable. ICRP Publication 22. Pergamon
Press, Oxford,
UK.
218.
ICRP, 1977.
Recommendations of the International Commission on Radiological
Protection. ICRP Publication 26. Ann. ICRP1 (3).
219.
ICRP, 1978.
Statement from the 1978 Stockholm Meeting of the
ICRP. ICRP Publication 28. Ann. ICRP2 (1).
220.
ICRP, 1979. Limits
for the intake of radionuclides by workers. ICRP Publication 30.
Part 1. Ann. ICRP2 (3/4).
221.
ICRP, 1980.
Biological effects of inhaled radionuclides. ICRP
Publication 31. Ann. ICRP4 (1/2).
222.
ICRP, 1983.
Cost-benefit analysis in the optimisation of radiation
protection. ICRP Publication 37. Ann. ICRP10 (2/3).
223.
ICRP, 1983b.
Radionuclide transformation: energy and intensity of
emissions. ICRP Publication 38. Ann. ICRP11–13.
224.
ICRP, 1984.
Non-stochastic effects of ionising radiation. ICRP
Publication 41. Ann. ICRP14 (3).
225.
ICRP, 1985a.
Protection of the patient in radiation therapy.
ICRP Publication 44. Ann. ICRP15 (2).
226.
ICRP, 1985b.
Quantitative bases for developing a unified index of
harm. ICRP Publication 45. Includes: Statement from the 1985 Paris
meeting of the ICRP. Ann. ICRP15 (3).
227.
ICRP, 1989.
Optimisation and decision-making in radiological
protection. ICRP Publication 55. Ann. ICRP20 (1).
228.
ICRP, 1989b. RBE for
deterministic effects. ICRP Publication 58. Ann.
ICRP20 (4).
229.
ICRP, 1991a. The
biological basis for dose limitation in the skin. ICRP Publication
59. Ann. ICRP22 (2).
230.
ICRP, 1991b. 1990
Recommendations of the International Commission on Radiological
Protection. ICRP Publication 60. Ann. ICRP21 (1–3).
231.
ICRP, 1991c.
Radiological protection in biomedical research.
ICRP Publication 62. Ann. ICRP22 (3).
232.
ICRP, 1992.
Principles for intervention for protection of the public in a
radiological emergency. ICRP Publication 63. Ann.
ICRP22 (4).
233.
ICRP, 1993a.
Protection from potential exposure: a conceptual
framework. ICRP Publication 64. Ann. ICRP23 (1).
234.
ICRP, 1993b.
Protection against radon-222 at home and at work.
ICRP Publication 65. Ann. ICRP23 (2).
235.
ICRP, 1993c.
Age-dependent doses to members of the public from intake of
radionuclides: Part 2. Ingestion dose coefficients. ICRP
Publication 67. Ann. ICRP23 (3/4).
236.
ICRP, 1994a. Human
respiratory tract model for radiological protection. ICRP
Publication 66. Ann. ICRP24 (1–3).
237.
ICRP, 1994b. Dose
coefficients for intakes of radionuclides by workers. ICRP
Publication 68. Ann. ICRP24 (4).
238.
ICRP, 1995a.
Age-dependent doses to members of the public from intake of
radionuclides: Part 3: Ingestion dose coefficients. ICRP
Publication 69. Ann. ICRP25 (1).
239.
ICRP, 1995b.
Age-dependent doses to members of the public from intake of
radionuclides: Part 4: Inhalation dose coefficients. ICRP
Publication 71. Ann. ICRP25 (3/4).
240.
ICRP, 1996a.
Radiological protection in medicine. ICRP
Publication 73. Ann. ICRP26 (2).
241.
ICRP, 1996b.
Conversion coefficients for use in radiological protection against
external radiation. ICRP Publication 74. Ann.
ICRP26 (3/4).
242.
ICRP, 1996c.
Age-dependent doses to members of the public from intake of
radionuclides: Part 5. Compilation of ingestion and inhalation dose
coefficients. ICRP Publication 72. Ann. ICRP26 (1).
243.
ICRP, 1997a. General
principles for the radiation protection of workers. ICRP
Publication 75. Ann. ICRP27 (1).
244.
ICRP, 1997b.
Protection from potential exposures: application to selected
radiation sources. ICRP Publication 76. Ann. ICRP27 (2).
245.
ICRP, 1997c.
Individual monitoring for internal exposure of
workers. ICRP Publication 78. Ann. ICRP27 (3–4).
246.
ICRP, 1997d.
Radiological protection policy for the disposal of radioactive
waste. ICRP Publication 77. Ann. ICRP27 (Suppl).
247.
ICRP, 1998a. Genetic
susceptibility to cancer. ICRP Publication 79. Ann.
ICRP28 (1–2).
248.
ICRP, 1998b.
Radiation protection recommendations as applied to the disposal of
long-lived solid radioactive waste. ICRP Publication 81.
Ann. ICRP28 (4).
249.
ICRP, 1999a.
Protection of the public in situations of prolonged radiation
exposure. ICRP Publication 82. Ann. ICRP29 (1–2).
250.
ICRP, 1999b. Risk
estimation for multifactorial diseases. ICRP Publication 83.
Ann. ICRP29 (3–4).
251.
ICRP, 2000a.
Pregnancy and medical radiation. ICRP Publication
84. Ann. ICRP30 (1).
252.
ICRP, 2000b.
Avoidance of radiation injuries from medical interventional
procedures. ICRP Publication 85. Ann. ICRP30 (2).
253.
ICRP, 2000c.
Prevention of accidental exposures to patients undergoing radiation
therapy. ICRP Publication 86. Ann. ICRP30 (3).
254.
ICRP, 2000d.
Managing patient dose in computed tomography. ICRP
Publication 87. Ann. ICRP30 (4).
255.
ICRP, 2001a. Doses
to the embryo and embryo/fetus from intakes of radionuclides by the
mother. ICRP Publication 88. Ann. ICRP31 (1–3).
256.
ICRP, 2001b.
Radiation and your patient: A guide for medical
practitioners. ICRP Supporting Guidance 2. Ann.
ICRP31 (4).
257.
ICRP, 2002. Basic
anatomical and physiological data for use in radiological
protection. ICRP Publication 89. Ann. ICRP32 (3/4).
258.
ICRP, 2003a.
Biological effects after prenatal irradiation (embryo and
fetus). ICRP Publication 90. Ann. ICRP33 (1/2).
259.
ICRP, 2003b. A
framework for assessing the impact of ionising radiation on non-human
species. ICRP Publication 91. Ann. ICRP33 (3).
260.
ICRP, 2003c.
Relative biological effectiveness (RBE), quality factor (Q), and
radiation weighting factor (wR). ICRP Publication 92. Ann.
ICRP33 (4).
261.
ICRP, 2004a.
Managing patient dose in digital radiology. ICRP
Publication 93. Ann. ICRP34 (1).
262.
ICRP, 2004b. Release
of patients after therapy with unsealed sources. ICRP Publication
94. Ann. ICRP34 (2).
263.
ICRP, 2004c. Doses
to infants from ingestion of radionuclides in mothers' milk. ICRP
Publication 95. Ann. ICRP34 (3/4).
264.
ICRP, 2005a.
Protecting people against radiation exposure in the event of a
radiological attack. ICRP Publication 96. Ann.
ICRP35 (1).
265.
ICRP, 2005b.
Prevention of high-dose-rate brachytherapy
accidents. ICRP Publication 97. Ann. ICRP35 (2).
266.
ICRP, 2005c.
Radiation safety aspects of brachytherapy for prostate cancer using
permanently implanted sources. ICRP Publication 98. Ann.
ICRP35 (3).
267.
ICRP, 2005d. Low
dose extrapolation of radiation-related cancer risk. ICRP
Publication 99. Ann. ICRP35 (4).
268.
ICRP, 2006a.
Assessing dose of the representative person for the purpose of
radiation protection of the public and The optimisation of radiological
protection: Broadening the process. ICRP Publication 101.
Ann. ICRP36 (3).
269.
ICRP, 2006b.
Analysis of the criteria used by the ICRP to justify the setting of
numerical values. Supporting Guidance 5. Ann.
ICRP36 (4).
270.
ICRP, 2006c. Human
alimentary tract model for radiological protection. ICRP
Publication 100. Ann. ICRP36 (1/2).
271.
ICRP, 2007a. Scope
of radiological protection control measures. ICRP Publication 104.
Ann. ICRP37 (4).
272.
ICRP, 2007b.
Radiological protection in medicine. ICRP
Publication 105. Ann. ICRP37 (5).
273.
ICRU, 1938.
Recommendations of the International Commission on Radiation Units,
Chicago, 1937. Am. J. Roentgenol., Radium Therapy Nucl.
Med. 39, 295.
274.
ICRU, 1951.
Recommendations of the International Commission on Radiation Units,
London, 1950. Radiology56, 117.
275.
ICRU, 1954.
Recommendations of the International Commission on Radiation Units,
Copenhagen, 1953. Radiology62, 106.
276.
ICRU, 1957. Report
of the International Commission on Radiation Units and
Measurements, Natl. Bur. Std Handbook62.
277.
ICRU, 1962.
Radiation Quantities and Units, Report 10a of the International
Commission on Radiation Units and Measurements, Natl. Bur.
Std Handbook78.
278.
ICRU, 1970. Linear Energy
Transfer. ICRU Report 16. ICRU
Publications: Bethesda,
MD.
279.
ICRU, 1985. Determination
of Dose Equivalents Resulting from External Radiation Sources. ICRU
Report 39. ICRU Publications:
Bethesda, MD.
280.
ICRU, 1986. The Quality
Factor in Radiation Protection. ICRU Report 40. ICRU
Publications: Bethesda,
MD.
281.
ICRU, 1988. Measurement of
Dose Equivalents from External Radiation Sources, Part 2. ICRU Report 43.
ICRU Publications: Bethesda,
MD.
282.
ICRU, 1992. Measurement of
Dose Equivalents from External Photon and Electron Radiations. ICRU
Report 47. ICRU Publications:
Bethesda, MD.
283.
ICRU, 1993a. Stopping
Powers and Ranges of Protons and Alpha Particles with Data Disk. ICRU
Report 49. ICRU Publications:
Bethesda, MD.
284.
ICRU, 1993b. Quantities and
Units in Radiation Protection Dosimetry. ICRU Report 51.
ICRU Publications: Bethesda,
MD.
285.
ICRU, 1997. Conversion
Coefficients for Use in Radiological Protection against External
Radiation. ICRU Report 57. ICRU
Publications: Bethesda,
MD.
286.
ICRU, 1998. Fundamental
Quantities and Units for Ionizing Radiation. ICRU Report 60.
ICRU Publications: Bethesda,
MD.
287.
ICRU, 2001a.
Quantities, units and terms in radioecology. ICRU
Report 65. Journal of ICRU1 (2).
288.
ICRU, 2001b.
Determination of operational dose equivalent quantities for
neutrons. ICRU Report 66. Journal of ICRU1 (3).
289.
IEC, 2005. International
Electrotechnical Vocabulary (IEV). Online database. IEV 393-04-13,
393-04-14, 393-04-15. International Electrotechnical
Commission, Geneva,
Switzerland.
290.
ISO, 1992.
Quantities and Units. ISO 31-9-34, 31-9-35, 31-9-36 (E).
International Organization for Standardization, Geneva, Switzerland. IXRPC, 1928.
X ray and Radium Protection. Recommendations of the 2nd International Congress of
Radiology, 1928. Br. J. Radiol.
12, 359–363.
291.
IXRPC, 1934.
International Recommendations for X ray and Radium Protection.
Revised by the International X ray and Radium Protection Commission and adopted by
the 4th International Congress of Radiology, Zurich, July 1934.
Br. J. Radiol. 7,
1–5.
292.
IXRUC, 1928.
International X ray unit of intensity. Recommendations of the 2nd
International Congress of Radiology, 1928. Br. J.
Radiol. 12,
363–364.
293.
IzumiS.SuyamaA.KoyamaK., 2003a. Radiation-related mortality among
offspring of atomic bomb survivors after a half-century of
follow-up. Int. J. Cancer107, 291–297.
294.
IzumiS.KoyamaK.SodaM.SuyamaA., 2003b. Cancer incidence in children and
young adults did not increase relative to parental exposure to atomic
bombs. Br. J. Cancer89, 1709–1713.
295.
JacobiW., 1975. The Concept of Effective Dose — A
Proposal for the Combination of Organ Doses. Radiat.
Environ. Biophys. 12,
101–109.
296.
JohnsonJ.R.MyersD.K.JacksonJ.S., 1995. Relative biological effectiveness
of tritium for induction of myeloid leukaemia. Radiat.
Res. 144,
82–89.
297.
JoinerM.C.MarplesB.LambinP., 2001. Low-dose hypersensitivity: current
status and possible mechanisms. Int. J. Radiat. Oncol.
Biol. Phys. 49,
379–389.
298.
JungH.Beck-BornholdtH.P.SvobodaV., 2001. Quantification of late
complications after radiation therapy. Radiother.
Oncol. 61,
233–246.
299.
KassisA.I.FayedF.KinseyB.M., 1989. Radiotoxicity of an I-125 labeled
DNA intercalator in mammalian cells. Radiat. Res.
118, 283–294.
300.
KaulA.AurandK.BonkaH., 1987. Possibilities and limits for
applying the concept of collective dose. Health
Phys. 53,
9–10.
301.
KaulA.BeckerD. (Eds.), 2005. Radiological
Protection. Landolt-Börnstein, Group VIII,
Vol. 4.
302.
KellererA.M., 1990. Rigour within uncertainty. ICRU
News, 3–6 December 1990, ICRU:
Bethesda, MD.
303.
KellererA.M.LeutholdG.MaresV., 2004. Options for the modified radiation
weighting factor of neutrons. Radiat. Prot.
Dosim. 109,
181–188.
304.
KirkK.M.LyonM.F., 1984. Induction of congenital
abnormalities in the offspring of male mice treated with x rays at pre-meiotic and
post-meiotic stages. Mutat. Res.
125, 75–85.
305.
KramerR.ZanklM.WilliamsG., 1982. The calculation of dose from external
photon exposures using reference human phantoms and Monte Carlo methods, Part I:
The male (Adam) and female (Eva) adult mathematical phantoms. GSF-Report
S-885, GSF-National Research Center for Environment and Health,
Neuherberg,
Germany.
306.
KrewskiD.LubinJ.H.ZielinskiJ.M., 2006. A combined analysis of North
American case-control studies of residential radon and lung
cancer. J. Toxicol. Environ. Health Part A69, 533–597.
307.
LafumaJ.NenotJ.C.MorinM., 1974. Respiratory carcinogenesis in rats
after inhalation of radioactive aerosols of actinides and lanthanides in various
chemical forms. In: KarbeE.ParksJ.F. (Eds.), Experimental Lung Cancer, Vol.
1, Springer Verlag, New
York, pp. 443–453.
308.
LeggettR.W.BouvilleA.EckermanK.F., 1998. Reliability of the ICRP's systemic
biokinetic models. Radiat. Protect. Dosim.
79, 335–342.
309.
LikhtarevI.MinenkoV.KhrouchV., 2003. Uncertainties in thyroid dose
reconstruction after Chernobyl. Radiat. Prot.
Dosim. 105,
601–608.
310.
LittleJ.B., 2003. Genomic instability and bystander
effects: a historical perspective. Oncogene22, 6978–6987.
311.
LohrerH.D.BraselmannH.RichterH.E., 2001. Instability of microsatellites in
radiation-associated thyroid tumours with short latency periods.
Int. J. Radiat. Biol. 77,
891–899.
312.
LubinJ.H.BoiceJ.D.Jr.EdlingC., 1995. Lung cancer in radon-exposed
miners and estimation of risk from indoor exposure. J.
Natl. Cancer. Inst. 87,
817–827.
313.
LubinJ.H.WangZ.Y.BoiceJ.D.Jr., 2004. Risk of lung cancer and
residential radon in China: pooled results of two studies.
Int. J. Cancer109 (1),
132–137.
314.
LyonM.F.RenshawR., 1988. Induction of congenital
malformation in mice by parental irradiation: transmission to later
generations. Mutat. Res. 198,
277–283.
315.
McGaleP.DarbyS.C., 2005. Low doses of ionizing radiation
and circulatory diseases: A systematic review of the published epidemiological
evidence. Radiat. Res. 163,
247–257.
316.
MichalowskiA., 1981. Effects of radiation on normal
tissues: hypothetical mechanisms and limitations of in situ assays of
clonogenicity. Radiat. Environ. Biophys.
19, 157–172.
317.
MinamotoA.TaniguchiH.YoshitaniN., 2004. Cataracts in atomic bomb
survivors. Int. J. Radiat. Biol.
80, 339–345.
318.
MitchelR.E.JacksonJ.S.McCannR.A.BorehamD.R., 1999. The adaptive response modifies
latency for radiation-induced myeloid leukaemia in CBA/H mice.
Radiat. Res. 152,
273–279.
319.
MitchelR.E.JacksonJ.S.MorrisonD.P.CarlisleS.M., 2003. Low doses of radiation increase
the latency of spontaneous lymphomas and spinal osteosarcomas in cancer-prone,
radiation-sensitive Trp53 heterozygous mice. Radiat.
Res. 159,
320–327.
320.
MorganW.F., 2003. Non-targeted and delayed effects
of exposure to ionizing radiation: I Radiation-induced genomic instability and
bystander effects in vitro. Radiat. Res.
159, 567–580.
321.
MoiseenkoV.V.WalkerA.J.PrestwichW.V., 1997. Energy deposition pattern from
tritium and different energy photons-a comparative study.
Health Phys. 73,
388–392.
322.
MothersillC.SeymourC., 2001. Radiation-induced bystander
effects: Past history and future directions. Radiat.
Res. 155,
759–767.
323.
MorstinK.KopecM.OlkoP., 1993. Microdosimetry of
tritium. Health Phys. 65,
648–656.
324.
NakanishiM.TanakaK.TakahashiT., 2001. Microsatellite instability in
acute myelocytic leukaemia developed from A-bomb survivors.
Int. J. Radiat. Biol. 77,
687–694 and Comments (2002), Int. J. Radiat. Biol.
78, 441–445.
325.
NAS/NRC, 2006.
Health risks from exposure to low levels of ionizing radiation:
BEIR VII Phase 2. Board on Radiation Effects
Research. National Research Council of the National
Academies, Washington,
D.C..
326.
NCI/CDC, 2003. Report of the
NCI-CDC Working Group to Revise the 1985 NIH Radioepidemiological Tables. NIH
Publication No. 03–5387. National Cancer Institute, Bethesda, MD.
327.
NCRP, 1974. Radiological
factors affecting decision-making in a nuclear attack. Report No. 42.
National Council on Radiation Protection and
Measurements, Bethesda,
MD.
328.
NCRP, 1989. Radiation
protection for medical and allied health personnel. Report No. 105.
National Council on Radiation Protection and
Measurements, Bethesda,
MD.
329.
NCRP, 1990. The Relative
Biological Effectiveness of Radiations of Different Quality. NCRP Report
No. 104. National Council on Radiation Protection and
Measurements. Bethesda,
MD.
330.
NCRP, 1995. Principles and
Application of Collective Dose in Radiation Protection. NCRP Report 121.
National Council on Radiation Protection and
Measurements. Bethesda,
MD.
331.
NCRP, 1997. Uncertainties
in Fatal Cancer Risk Estimates used in Radiation Protection. NCRP Report
126. National Council on Radiation Protection and
Measurements, Bethesda
MD.
332.
NCRP, 1999. Biological
Effects and Exposure Limits for ‘Hot Particles’. NCRP Report 130.
National Council on Radiation Protection and
Measurements. Bethesda,
MD.
333.
NCRP, 2001. Evaluation of
the Linear-Non threshold Dose-Response Model for Ionizing Radiation. NCRP
Report No. 136. National Council on Radiation Protection and
Measurements, Bethesda
MD.
334.
NCRP, 2006. Development of
a Biokinetic Model for Radionuclide-Contaminated Wounds and Procedures for Their
Assessment, Dosimetry and Treatment. NCRP Report No. 156.
National Council on Radiation Protection and
Measurements, Bethesda,
MD.
335.
NEA, 2005. Nuclear
Regulatory Decision Making. Nuclear Energy Agency,
Organisation for Economic Co-operation and Development,
Paris, France.
336.
NelsonC.B.PhippsA.W.SilkT.J., 1997. The ICRP Publication 60
formulation of remainder dose and its contribution to effective dose in internal
dosimetry. Radiat. Prot. Dosim.
71, 33–40.
337.
NolteR.M.ÜhlbradtK.H.MeuldersJ.P., 2005. RBE of quasi-monoenergetic 60 MeV
neutron radiation for induction of dicentric chromosome aberrations in human
lymphocytes. Radiat. Environ. Biophys.
44, 201–209.
338.
NomuraT., 1982. Parental exposure to X-rays and
chemicals induces heritable tumors and anomalies in mice.
Nature296, 575–577.
339.
NomuraT., 1988. X-ray and chemically induced germ
line mutations causing phenotypic anomalies in mice.
Mutat. Res. 198,
309–320.
340.
NomuraT., 1994. Male-mediated teratogenesis:
ionizing radiation and ethylnitrosourea studies. In: MattisonD.R.OlshanA.F. (Eds.), Male-mediated Developmental Toxicity.
Plenum Press, New
York, pp. 117–127.
341.
NRC, 1972. National Academy
of Sciences-National Research Council, The BEIR Report.
National Academy Press,
Washington, D.C..
342.
NRC, 1990. National Academy
of Sciences-National Research Council, The BEIR V Report.
National Academy Press,
Washington, D.C..
343.
NUREG, 1998. Probabilistic
accident consequence uncertainty analysis — Early health effects uncertainty
assessment. CR-6545/EUR 16775. US Nuclear Regulatory
Commission, Washington DC, USA,
and Commission of the European Communities,
Brussels, Belgium.
344.
OkunieffP.MesterM.WangJ., 1998. In-vivo radioprotective effects of
angiogenic growth factors on the small bowel of C3H mice.
Radiat. Res. 150,
204–211.
345.
OtakeM.SchullW.J., 1990. Radiation-related posterior
lenticular opacities in Hiroshima and Nagasaki atomic bomb survivors based on the
DS86 dosimetry system. Radiat. Res.
121, 3–31.
346.
ParkinD.M.WhelanS.L.FerlayJ. (Eds.), 2002. Cancer Incidence in Five
Continents Vol VIII. IARC Scientific Publications No. 155.
International Agency for Research on
Cancer.
347.
Lyon. PelliccioniM., 1998. Radiation weighting factors and
high energy radiation. Radiat. Prot. Dosim.
80, 371–378.
348.
PelliccioniM., 2004. The impact of ICRP Publication 92
on the conversion coefficients in use for cosmic ray dosimetry.
Radiat. Prot. Dosim. 109,
303–309.
349.
PentreathR.J., 2005. Concept and use of reference
animals and plants. In: Protection of the Environment from
the Effects of Ionizing Radiation, IAEA-CN–109,
IAEA, Vienna,
411–420.
350.
PierceD.A.SharpG.B.MabuchiK., 2003. Joint effects of radiation and
smoking on lung cancer risk among atomic bomb survivors.
Radiat. Res. 159,
511–520.
351.
PierceD.A.StramD.O.VaethM., 1990. Allowing for random errors in
radiation dose estimates for the atomic bomb survivor data.
Radiat. Res. 123,
275–284.
352.
PrestonD.L.KusumiS.TomonagaM., 1994. Cancer incidence in atomic bomb
survivors. Part III. Leukaemia, lymphoma and multiple myeloma,
1950–1987. Radiat. Res. 137,
S68–S97.
353.
PrestonD.L.MattssonA.HolmbergE., 2002. Radiation effects on breast cancer
risk: a pooled analysis of eight cohorts. Radiat.
Res. 158,
220–235.
354.
PrestonD.L.ShimizuY.PierceD.A.2003. Studies of mortality of atomic bomb
survivors. Report 13: Solid cancer and non-cancer disease
mortality 1950–1997. Radiat. Res. 160:
381–407.
355.
PrestonD.L.PierceD.A.ShimizuY., 2004. Effect of recent changes in atomic
bomb survivor dosimetry on cancer mortality risk estimates.
Radiat. Res. 162,
377–389.
356.
PrestonD.L.RonE.TokuokaS., 2007. Solid cancer incidence in atomic
bomb survivors: 1958–98. Radiat. Res.
168, 1–64.
357.
PuskinJ.S.NelsonN.S.NelsonC.B., 1992. Bone cancer risk
estimates. Health Phys. 63,
579–580.
358.
RaoD.V.NarraV.R.HowellR.W., 1990. Biological consequences of nuclear
versus cytoplasmic decays of 125I: cysteamine as a radioprotector against Auger
cascades in vivo. Radiat. Res.
124, 188–193.
359.
RonE.LubinJ.H.ShoreR.E., 1995. Thyroid cancer after exposure to
external radiation: a pooled analysis of seven studies.
Radiat. Res. 141,
259–277.
360.
RubinP.FinklesteinJ.N.WilliamsJ.P., 1998. Paradigm shifts in the radiation
pathophysiology of late effects in normal tissues: molecular vs classical
concepts. In: TobiasJ.S.ThomasP.R.M. (Eds.), Current Radiation Oncology, Vol
3. Arnold,
London.
361.
SankaranarayananK., 1991. Genetic effects of ionising
radiation in man. Ann. ICRP22, 76–94.
362.
SankaranarayananK., 1998. Ionizing radiation and genetic
risks. IX. Estimates of the frequencies of mendelian diseases and spontaneous
mutation rates in human populations: a 1998 perspective.
Mutat. Res. 411,
129–178.
363.
SankaranarayananK., 1999. Ionizing radiation and genetic
risks. X. The potential ‘disease phenotypes’ of radiation-induced genetic damage
in humans: perspectives from human molecular biology and radiation
genetics. Mutat. Res. 429,
45–83.
364.
SankaranarayananK.ChakrabortyR., 2000a. Ionizing radiation and genetic
risks. XI. The doubling-dose estimates from the mid 1950s to the present, and the
conceptual change to the use of human data on spontaneous mutation rates and mouse
data on induced mutation rates for doubling-dose calculations.
Mutat. Res. 453,
107–127.
365.
SankaranarayananK.ChakrabortyR., 2000b. Ionizing radiation and genetic
risks. XII. The concept of ‘potential recoverability correction factor’ (PRCF) and
its use for predicting the risk of radiationinducible genetic disease in human
live births. Mutat. Res. 453,
129–181.
366.
SankaranarayananK.ChakrabortyR., 2000c. Ionizing radiation and genetic
risks. XIII. Summary and synthesis of papers VI to XII and estimates of genetic
risks in the year 2000. Mutat. Res.
453, 183–197.
367.
SankaranarayananK.ChakrabortyR.BoerwinkleE.A., 1999. Ionizing radiation and genetic
risks. VI. Chronic multifactorial diseases: a review of epidemiological and
genetic aspects of coronary heart disease, essential hypertension and diabetes
mellitus. Mutat. Res. 436,
21–57.
368.
SankaranarayananK.YasudaN.ChakrabortyR., 1994. Ionizing radiation and genetic
risks. V. Multifactorial diseases: a review of epidemiological and genetic aspects
of congenital abnormalities in man and of models on maintenance of quantitative
traits in populations. Mutat. Res.
317, 1–23.
369.
SasakiM.S., 1991. Primary damage and fixation of
chromosomal DNA as probed by monochromatic soft x rays and low-energy
neutrons. In: FieldenE.M.O'NeilP. (Eds.), The Early Effects of Radiation on DNA. NATO
ASI Series, Vol. H54, Springer
Verlag, Berlin, Germany, pp.
369–384.
370.
SatoT.TsudaS.SakamotoY., 2003. Analysis of dose-LET distribution
in the human body irradiated by high energy hadrons.
Radiat. Prot. Dosim. 106,
145–153.
371.
SatoT.TsudaS.SakamotoY., 2004. Profile of energy deposition in
human body irradiated by heavy ions. J. Nucl. Sci.
Technol. Suppl. 4,
287–290.
372.
SchlattlH.ZanklM.Petoussi-HenssN., 2007. Organ dose conversion coefficients
for voxel models of the reference male and female from idealized photon
exposures. Phys. Med. Biol. 52,
2123–2145.
373.
SchmidE.RegullaD.KramerH.M., 2002. The effect of 29 kV X-rays on the
dose response of chromosome aberrations in human lymphocytes.
Radiat. Res. 158,
771–777.
374.
SchmidE.SchlegelD.GuldbakkeS., 2003. RBE of nearly monoenergetic
neutrons at energies of 36 keV — 14.6 MeV for induction of dicentrics in human
lymphocytes. Radiat. Environm. Biophys.
42, 87–94.
375.
ScottB.R., 1993. Early occurring and continuing
effects. In: Modification of models resulting from
addition of effects of exposure to alpha-emitting nuclides.
Washington, D.C., Nuclear
Regulatory Commission, NUREG/CR-4214, Rev 1, Part II, Addendum 2
(LMF-136).
376.
ScottB.R.HahnF.F., 1989. Early occurring and continuing effects
models for nuclear power plant accident consequence analysis. Low-LET
radiation. Washington DC, Nuclear
Regulatory Commission, NUREG/CR-4214 (SAND85-7185) Rev. 1, Part
II.
377.
SearleA.G.BeecheyC.V., 1986. The role of dominant visibles in
mutagenicity testing. In: RamelC. (Eds.), Genetic Toxicology of Environmental Chemicals, Part
B, Genetic Effects and Applied Mutagenesis. Alan R.
Liss, New York,
511–518.
378.
SelbyP.B., 1998. Discovery of numerous clusters of
spontaneous mutations in the specific locus test in mice necessitates major
increases in estimates of doubling doses.
Genetica102/103, 463–487.
379.
SelbyP.B.SelbyP.R., 1977. Gamma-ray-induced dominant
mutations that cause skeletal abnormalities in mice. I. Plan, summary of results
and discussion. Mutat. Res. 43,
357–375.
380.
SnyderW.S.FordM.R.WarnerG.G., 1969. Medical Internal Radiation Dose
Committee (MIRD) Pamphlet No. 5. J. Nucl. Med.
10, Supplement No. 3.
381.
SSK, 2005.
Bundesministerium für Umwelt, Naturschutz und Reaktorsicherheit.
Vergleichende Bewertung der biologischen Wirksamkeit verschiedener ionisierender
Strahlungen. Veröffentlichungen der
Strahlenschutzkommission, Bd. 53. Verlag
Elsevier/Urban und Fischer.
382.
StraumeT.CarstenA.L., 1993. Tritium radiobiology and relative
biological effectiveness. Health Phys.
65, 657–672.
383.
StrefferC., 2005. Can tissue weighting factors be
established for the embryo and fetus? Radiat. Prot.
Dosim. 112,
519–523.
384.
StrefferC.van BeuningenD.EliasS., 1978. Comparative effects of tritiated
water and thymidine on the preimplanted mouse embryo in vitro.
Curr. Topics Radiat. Res. 12,
182–193.
385.
StrefferC.BoltH.FollesdalD., 2004. Low Dose Exposures in the
Environment: Dose-Effect Relations and Risk Evaluation.
Wissenschaftsethik und Technikfolgenbeurteilung, Band
23. Springer, Berlin,
Germany.
386.
TawnE.J.WhitehouseC.A.TaroneR.E., 2004. FISH Chromosome analysis of
retired radiation workers from the Sellafield nuclear facility.
Radiat. Res. 162,
249–256.
387.
ThackerJ.NygaardO.F.SinclairW.K., 1992. Radiation induced mutation in
mammalian cells at low doses and dose rates. Advances in
Radiation Biology, Vol. 16. Academic
Press Inc, New York, pp.
77–124.
388.
ThompsonD.E.MabuchiK.RonE., 1994. Cancer Incidence in atomic bomb
survivors. Part II: Solid tumours, 1958–1987. Radiat.
Res.
137:S17–S67.
389.
TravisL.B.GospodarowiczM.CurtisR.E., 2002. Lung cancer following chemotherapy
and radiotherapy for Hodgkin's disease. J. Natl. Cancer
Inst. 94,
182–192.
390.
TubianaM.AurengoA.AverbeckD., 2005. Dose-effect relationships and estimation
of the carcinogenic effects of low doses of ionizing radiation.
Académie des Sciences — Académie Nationale de
Médecine, Paris, France,
94 pp. (http://www.academie-sciences.fr/publications/raports/pdf/dose).
391.
TuckerJ.D.TawnE.J.HoldsworthD., 1997. Biological dosimetry of radiation
workers at the Sellafield nuclear facility. Radiat.
Res. 148,
216–226.
392.
UenoA.M.Furuno-FukushiI.MatsudairaH., 1989. Cell killing and mutation to
6-thioguanine resistance after exposure to tritiated amino acids and tritiated
thymidine in cultured mammalian cells. In: OkadaS. (Ed.), Tritium Radiobiology and Health Physics.
Proc. 3rd Japanese—US Workshop. IPPJ-REV-3, Nagoya
University, Japan, pp.
200–210.
393.
UNESCO, 2005. The
Precautionary Principle. United Nations Educational,
Scientific and Cultural Organization, Paris,
France.
394.
UNSCEAR, 1972.
United Nations Scientific Committee on the Effects of Atomic
Radiation. Sources and Effects of Ionizing
Radiation. 1972 Report to the General Assembly with Annexes,
United Nations, New
York.
395.
UNSCEAR, 1977.
United Nations Scientific Committee on the Effects of Atomic
Radiation. Sources and Effects of Ionizing
Radiation. 1977 Report to the General Assembly with Annexes,
United Nations, New
York.
396.
UNSCEAR, 1988.
United Nations Scientific Committee on the Effects of Atomic
Radiation. Sources, Effects and Risks of Ionizing
Radiation. 1988 Report to the General Assembly with Annexes,
United Nations, New
York.
397.
UNSCEAR, 1993.
United Nations Scientific Committee on the Effects of Atomic
Radiation. Sources and Effects of Ionizing
Radiation. 1993 Report to the General Assembly with Scientific Annexes,
United Nations, New
York.
398.
UNSCEAR, 1994.
United Nations Scientific Committee on the Effects of Atomic
Radiation. Sources and Effects of Ionizing
Radiation. 1994 Report to the General Assembly with Scientific Annexes,
United Nations, New
York.
399.
UNSCEAR, 2000.
Sources and Effects of Ionizing Radiation.
United Nations Scientific Committee on the Effects of Atomic Radiation
Report to the General Assembly with Scientific Annexes. Vol. II: Effects.
United Nations, New York,
NY.
400.
UNSCEAR, 2000a. Sources and
Effects of Ionizing Radiation. Report of the United National Scientific
Committee on the Effects of Atomic Radiation. 2000 Report to the General Assembly,
with scientific annexes. Volume I: Sources. United
Nations, New
York.
401.
UNSCEAR, 2001. Hereditary
Effects of Ionizing Radiation. United Nations Scientific Committee on the
Effects of Atomic Radiation Report to the General Assembly with Scientific Annexes.
United Nations, New York,
NY.
402.
UNSCEAR, 2008. Effects of
Ionizing Radiation. United Nations Scientific Committee on the Effects of
Atomic Radiation Report to the General Assembly with Scientific
Annexes.
403.
van der KogelA.J., 2002. Radiation response and tolerance
of normal tissues. In: SteelG.G. (Ed.), Basic Clinical Radiobiology.
Arnold,
London.
404.
WangJ.AlbertsonC.M.ZhengH., 2002. Short-term inhibition of
ADP-induced platelet aggregation by clopidogrel ameliorates radiation-induced
toxicity in rat small intestine. Thromb. Haemost.
87, 122–128.
405.
WartersR.L.HoferK.G.HarrisC.R., 1977. Radionuclide toxicity in cultured
mammalian cells: elucidation of the primary site of radiation
damage. Curr. Topics Radiat. Res. Q.
12, 389–407.
406.
WheldonT.E.MichalowskiA.S.KirkJ., 1982. The effect of irradiation on
function in self-renewing normal tissues with differing proliferative
organisation. Br. J. Radiol. 55,
759–766.
407.
WHO, 2001. IARC Monographs
on the evaluation of carcinogenic risks to humans. Vol.
78. Ionizing Radiation, Part 2: some internally deposited radionuclides.
World Health Organisation, International Agency for Research on Cancer.
IARC Press,
Lyon.
408.
WithersH.R.TaylorJ.M.MaciejewskiB., 1988. Treatment volume and tissue
tolerance. Int. J. Radiat. Oncol. Biol. Phys.
14, 751–759.
409.
YoshizawaN.SatoO.TakagiS., 1998. External radiation conversion
coefficients using radiation weighting factor and quality factor for neutron and
proton from 20 MeV to 10 GeV. Nucl. Sci. Techn.
35 (12),
928–942.
410.
ZanklM.FillU.Petoussi-HenssN., 2002. Organ dose conversion coefficients
for external photon irradiation of male and female voxel phantoms.
Phys. Med. Biol. 47 (14),
2367–2385.
411.
ZanklM.BeckerJ.FillU., 2005. GSF male and female adult voxel models
representing ICRP reference man — the present status. Proceedings of The
Monte Carlo Method: Versatility Unbounded in a Dynamic Computing World. Chattanooga,
TN, American Nuclear Society, La
Grange Park, USA.
412.
ZanklM.EckermanK.F.BolchW.E., 2007. Voxel-based models representing
the male and female ICRP reference adult — the skeleton.
Radiat. Prot. Dosim. 127.
